MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

12 hedge funds and large institutions have $5.32M invested in Merrimack Pharmaceuticals, Inc. in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$232K
2
+$1.19K
3
+$1.15K

Top Sellers

1
-$32.1M
2
-$27.7M
3
-$13.3M
4
BlackRock
BlackRock
New York
-$10.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$9.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
1 2
3